These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23037163)

  • 1. Anti-Pseudomonas aeruginosa compound, 1,2,3,4-tetrahydro-1,3,5-triazine derivative, exerts its action by primarily targeting MreB.
    Yamachika S; Sugihara C; Tsuji H; Muramatsu Y; Kamai Y; Yamashita M
    Biol Pharm Bull; 2012; 35(10):1740-4. PubMed ID: 23037163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM.
    Robertson GT; Doyle TB; Du Q; Duncan L; Mdluli KE; Lynch AS
    J Bacteriol; 2007 Oct; 189(19):6870-81. PubMed ID: 17644596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-biofilm activity of A22 ((S-3,4-dichlorobenzyl) isothiourea hydrochloride) against Pseudomonas aeruginosa: Influence on biofilm formation, motility and bioadhesion.
    Bonez PC; Rossi GG; Bandeira JR; Ramos AP; Mizdal CR; Agertt VA; Dalla Nora ESS; de Souza ME; Dos Santos Alves CF; Dos Santos FS; Gündel A; de Almeida Vaucher R; Santos RCV; de Campos MMA
    Microb Pathog; 2017 Oct; 111():6-13. PubMed ID: 28804018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa.
    Siriyong T; Srimanote P; Chusri S; Yingyongnarongkul BE; Suaisom C; Tipmanee V; Voravuthikunchai SP
    BMC Complement Altern Med; 2017 Aug; 17(1):405. PubMed ID: 28806947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that a novel quaternary compound and its organic N-chloramine derivative do not select for resistant mutants of Pseudomonas aeruginosa.
    De Silva M; Ning C; Ghanbar S; Zhanel G; Logsetty S; Liu S; Kumar A
    J Hosp Infect; 2015 Sep; 91(1):53-8. PubMed ID: 26122622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial, cyto and genotoxic activities of A22 compound ((S-3, 4 -dichlorobenzyl) isothiourea hydrochloride).
    Bonez PC; Ramos AP; Nascimento K; Copetti PM; Souza ME; Rossi GG; Agertt VA; Sagrillo MR; Santos RC; Campos MM
    Microb Pathog; 2016 Oct; 99():14-18. PubMed ID: 27427089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations Reducing
    Jones AK; Caughlan RE; Woods AL; Uehara K; Xie L; Barnes SW; Walker JR; Thompson KV; Ranjitkar S; Lee PS; Dean CR
    Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31658970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Antibacterial and Antibiofilm Activity of the MreB Inhibitor A22 Hydrochloride in Combination with Conventional Antibiotics against
    Kotzialampou A; Protonotariou E; Skoura L; Sivropoulou A
    Int J Microbiol; 2021; 2021():3057754. PubMed ID: 34484344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
    Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
    Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical characterization and evaluation of potent inhibitors of the Pseudomonas aeruginosa PA01 acetohydroxyacid synthase.
    Cho JH; Lee MY; Baig IA; Ha NR; Kim J; Yoon MY
    Biochimie; 2013 Jul; 95(7):1411-21. PubMed ID: 23523771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meropenem potentiation of aminoglycoside activity against Pseudomonas aeruginosa: involvement of the MexXY-OprM multidrug efflux system.
    Poole K; Gilmour C; Farha MA; Parkins MD; Klinoski R; Brown ED
    J Antimicrob Chemother; 2018 May; 73(5):1247-1255. PubMed ID: 29420743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex.
    Nicholson A; Perry JD; James AL; Stanforth SP; Carnell S; Wilkinson K; Anjam Khan CM; De Soyza A; Gould FK
    Int J Antimicrob Agents; 2012 Jan; 39(1):27-32. PubMed ID: 21993484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RELATIVE EXPRESSION OF EFFLUX PUMPS IN MULTI DRUG RESISTANT PSEUDOMONAS AERUGINOSA.
    Azimi L; Namvar AE; Jamali S; Lari AR; Bijari A; Lari AR
    Roum Arch Microbiol Immunol; 2015; 74(3-4):86-90. PubMed ID: 27328522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.
    Adamson DH; Krikstopaityte V; Coote PJ
    J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa.
    Pan YP; Xu YH; Wang ZX; Fang YP; Shen JL
    Arch Microbiol; 2016 Aug; 198(6):565-71. PubMed ID: 27060003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of compound 48/80-sensitized Pseudomonas aeruginosa to the hydrophobic biocide triclosan.
    Ellison ML; Roberts AL; Champlin FR
    FEMS Microbiol Lett; 2007 Apr; 269(2):295-300. PubMed ID: 17263842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative to antibiotics against Pseudomonas aeruginosa: Effects of Glycyrrhiza glabra on membrane permeability and inhibition of efflux activity and biofilm formation in Pseudomonas aeruginosa and its in vitro time-kill activity.
    Chakotiya AS; Tanwar A; Narula A; Sharma RK
    Microb Pathog; 2016 Sep; 98():98-105. PubMed ID: 27392698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in Pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis.
    Chalhoub H; Sáenz Y; Nichols WW; Tulkens PM; Van Bambeke F
    Int J Antimicrob Agents; 2018 Nov; 52(5):697-701. PubMed ID: 30081137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa.
    Hirakata Y; Kondo A; Hoshino K; Yano H; Arai K; Hirotani A; Kunishima H; Yamamoto N; Hatta M; Kitagawa M; Kohno S; Kaku M
    Int J Antimicrob Agents; 2009 Oct; 34(4):343-6. PubMed ID: 19615866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidation of the Mode of Action of a New Antibacterial Compound Active against Staphylococcus aureus and Pseudomonas aeruginosa.
    Gerits E; Blommaert E; Lippell A; O'Neill AJ; Weytjens B; De Maeyer D; Fierro AC; Marchal K; Marchand A; Chaltin P; Spincemaille P; De Brucker K; Thevissen K; Cammue BP; Swings T; Liebens V; Fauvart M; Verstraeten N; Michiels J
    PLoS One; 2016; 11(5):e0155139. PubMed ID: 27167126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.